Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Method using 5,10,15,20-tetrakis(4-carboxyphenyl)porphine for treating cancers of the lung

Patent ·
OSTI ID:869755

Method using tetra-aryl porphyrins for and, in particular, 5,10,15,20-tetrakis(4-carboxyphenyl)porphine as a fluorescent tracer for cancers of the lung, and as a radiotracer therefor as a complex with .sup.67 Cu. The latter complex also provides a source of beta radiation for selective destruction of lung malignancies as well as gamma radiation useful for image analysis of the situs thereof by single photon emission computed tomography, as an example, both in vivo. Copper-64 may be substituted for the .sup.67 Cu if only radiotracer characteristics are of interest. This lighter isotope of copper is a positron emitter, and positron emission tomography techniques can be used to locate the malignant tissue mass.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM
DOE Contract Number:
W-7405-ENG-36
Assignee:
University of California Office of Technology Transfer (Alameda, CA)
Patent Number(s):
US 5391547
OSTI ID:
869755
Country of Publication:
United States
Language:
English

References (2)

Preparation and characterization of copper-67 porphyrin-antibody conjugates journal December 1987
Early Detection of Lung Cancer by Means of Hematoporphyrin Derivative Fluorescence and Laser Photoradiation journal June 1985